Remicade and Pericarditis tuberculous - a phase IV clinical study of FDA data

Summary:

Pericarditis tuberculous is reported as a side effect among people who take Remicade (infliximab), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Sulfasalazine, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Pericarditis tuberculous when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Pericarditis tuberculous?

Pericarditis tuberculous (tuberculosis infection of the pericardial membrane (pericardium) covering the heart) is found to be associated with 16 drugs and 53 conditions by eHealthMe. Check the latest studies of Pericarditis tuberculous.

On Jul, 07, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 27 people (0.01%) have Pericarditis tuberculous.

Could Remicade cause Pericarditis tuberculous?

Among these 27 people:

How long have people been on Remicade when they have Pericarditis tuberculous? *

What is the gender of people who have Pericarditis tuberculous when taking Remicade? *

female: 34.62 %
male: 65.38 %

What is the age of people who have Pericarditis tuberculous when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Pericarditis tuberculous? *

Disseminated Tuberculosis: 10 people, 37.04%
Pulmonary Tuberculosis (lungs tuberculosis): 9 people, 33.33%
Lymph Node Tuberculosis: 6 people, 22.22%
Tuberculous Pleurisy (an inflammation of lung covering plura by mycobacterium tuberculosis): 5 people, 18.52%
Cardiac Tamponade (fluid accumulates in heart covering): 4 people, 14.81%
Pancreatitis Acute (sudden inflammation of pancreas): 2 people, 7.41%
General Physical Health Deterioration (weak health status): 2 people, 7.41%
Infusion Related Reaction: 2 people, 7.41%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 7.41%
Pericardial Effusion (fluid around the heart): 1 person, 3.70%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 18.52%
Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 18.52%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 11.11%
Itching: 2 people, 7.41%
Gastric Ulcer (stomach ulcer): 2 people, 7.41%
Diarrhea: 2 people, 7.41%
Uveitis (inflammation of the uvea): 1 person, 3.70%
Birth Control: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Pericarditis tuberculous?

- Check whether Pericarditis tuberculous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pericarditis tuberculous:

Pericarditis tuberculous (16 drugs)

Browse all the conditions that are associated with Pericarditis tuberculous:

Pericarditis tuberculous (53 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.